Acetyl‐coenzyme A carboxylases: Versatile targets for drug discovery

Acetyl‐coenzyme A carboxylases (ACCs) have crucial roles in fatty acid metabolism in humans and most other living organisms. They are attractive targets for drug discovery against a variety of human diseases, including diabetes, obesity, cancer, and microbial infections. In addition, ACCs from grasses are the targets of herbicides that have been in commercial use for more than 20 years. Significant progresses in both basic research and in drug discovery have been made over the past few years in the studies on these enzymes. At the basic research level, the crystal structures of the biotin carboxylase (BC) and the carboxyltransferase (CT) components of ACC have been determined, and the molecular basis for ACC inhibition by small molecules are beginning to be understood. At the drug discovery level, a large number of nanomolar inhibitors of mammalian ACCs have been reported and the extent of their therapeutic potential is being aggressively explored. This review summarizes these new progresses and also offers some prospects in terms of the future directions for the studies on these important enzymes. J. Cell. Biochem. 99: 1476–1488, 2006. © 2006 Wiley‐Liss, Inc.

[1]  H. Sham,et al.  Synthesis and Structure−Activity Relationships of N-{3-[2-(4-Alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy Derivatives as Selective Acetyl-CoA Carboxylase 2 Inhibitors , 2006 .

[2]  David M. Wallace,et al.  Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors. , 2006, Journal of medicinal chemistry.

[3]  T. Watts,et al.  Identification of an isozymic form of acetyl-CoA carboxylase. , 1990, The Journal of biological chemistry.

[4]  H M Holden,et al.  Movement of the Biotin Carboxylase B-domain as a Result of ATP Binding* , 2000, The Journal of Biological Chemistry.

[5]  G. Lopaschuk,et al.  AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. , 2003, Progress in lipid research.

[6]  H. J. Harwood,et al.  Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition. , 2005, Expert opinion on therapeutic targets.

[7]  J. McGarry,et al.  The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.

[8]  J. Cronan,et al.  Function of Escherichia coli Biotin Carboxylase Requires Catalytic Activity of Both Subunits of the Homodimer* , 2001, The Journal of Biological Chemistry.

[9]  Thomas Lampe,et al.  Identification and Characterization of the First Class of Potent Bacterial Acetyl-CoA Carboxylase Inhibitors with Antibacterial Activity* , 2004, Journal of Biological Chemistry.

[10]  Eva Dizin,et al.  BRCA1 Affects Lipid Synthesis through Its Interaction with Acetyl-CoA Carboxylase* , 2006, Journal of Biological Chemistry.

[11]  Liang Tong,et al.  Crystal Structure of the Carboxyltransferase Domain of Acetyl-Coenzyme A Carboxylase , 2003, Science.

[12]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[13]  K. Kim,et al.  Regulation of mammalian acetyl-coenzyme A carboxylase. , 1997, Annual review of nutrition.

[14]  Grover L Waldrop,et al.  The structure of the carboxyltransferase component of acetyl-coA carboxylase reveals a zinc-binding motif unique to the bacterial enzyme. , 2006, Biochemistry.

[15]  D. Hargrove,et al.  Isozyme-nonselective N-Substituted Bipiperidylcarboxamide Acetyl-CoA Carboxylase Inhibitors Reduce Tissue Malonyl-CoA Concentrations, Inhibit Fatty Acid Synthesis, and Increase Fatty Acid Oxidation in Cultured Cells and in Experimental Animals* , 2003, Journal of Biological Chemistry.

[16]  J. Swinnen,et al.  RNA Interference–Mediated Silencing of the Acetyl-CoA-Carboxylase-α Gene Induces Growth Inhibition and Apoptosis of Prostate Cancer Cells , 2005 .

[17]  M. Prentki,et al.  AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome , 2004, Nature Reviews Drug Discovery.

[18]  K. Kim,et al.  Identification of a second human acetyl-CoA carboxylase gene. , 1996, The Biochemical journal.

[19]  Liang Tong,et al.  Molecular basis for the inhibition of the carboxyltransferase domain of acetyl-coenzyme-A carboxylase by haloxyfop and diclofop. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Volrath,et al.  Expression and characterization of recombinant fungal acetyl-CoA carboxylase and isolation of a soraphen-binding domain. , 2004, The Biochemical journal.

[21]  L. Tong,et al.  Acetyl-coenzyme A carboxylase: crucial metabolic enzyme and attractive target for drug discovery , 2005, Cellular and Molecular Life Sciences CMLS.

[22]  Olga Anczuków,et al.  Acetyl-CoA carboxylase alpha gene and breast cancer susceptibility. , 2004, Carcinogenesis.

[23]  G. Lopaschuk,et al.  Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. , 2003, American journal of physiology. Endocrinology and metabolism.

[24]  Shin Kondo,et al.  Structure of the biotin carboxylase subunit of pyruvate carboxylase from Aquifex aeolicus at 2.2 A resolution. , 2004, Acta crystallographica. Section D, Biological crystallography.

[25]  David Millington,et al.  Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.

[26]  G. Shulman,et al.  Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. , 2006, The Journal of clinical investigation.

[27]  L. Tong,et al.  Crystal structure of the carboxyltransferase domain of acetyl-coenzyme A carboxylase in complex with CP-640186. , 2004, Structure.

[28]  R. Brownsey,et al.  Inhibition of Acetyl-CoA Carboxylase Isoforms by Pyridoxal Phosphate* , 2005, Journal of Biological Chemistry.

[29]  S. Wakil,et al.  Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Tong,et al.  Is dimerization required for the catalytic activity of bacterial biotin carboxylase? , 2006, Molecular cell.

[31]  G. Waldrop,et al.  A bisubstrate analog inhibitor of the carboxyltransferase component of acetyl-CoA carboxylase. , 2002, Biochemical and biophysical research communications.

[32]  Liang Tong,et al.  A mechanism for the potent inhibition of eukaryotic acetyl-coenzyme A carboxylase by soraphen A, a macrocyclic polyketide natural product. , 2004, Molecular cell.

[33]  S. Chirala,et al.  The subcellular localization of acetyl-CoA carboxylase 2. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H M Holden,et al.  Three-dimensional structure of the biotin carboxylase subunit of acetyl-CoA carboxylase. , 1994, Biochemistry.

[35]  M. Lane,et al.  Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure. , 2005, Biochemical Society transactions.

[36]  R. Brownsey,et al.  Regulation of acetyl-CoA carboxylase. , 2006, Biochemical Society transactions.

[37]  Ziwei Gu,et al.  Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Müller,et al.  Myxobacteria: proficient producers of novel natural products with various biological activities--past and future biotechnological aspects with the focus on the genus Sorangium. , 2003, Journal of biotechnology.

[39]  S. Chirala,et al.  Glucose and fat metabolism in adipose tissue of acetyl-CoA carboxylase 2 knockout mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.